Genmab — Maj 2020

[Sukkeralf]

me too

[Sukkeralf]

Faldet sker trods alt heller ikke under voldsom omsætning, så vi kan hurtigt komme den anden vej igen. Men gevinsthjemtagning må jo komme før eller siden.

[Sukkeralf]

Ønske scenariet lige nu ville være LBA med dara i amyloidosis i morgen og epcoritmab data fredag samt partner aftale !

[Sukkeralf]

Hvis en evt partner køber sig ind i Genmab, så kan det jo være de lige har bestilt en rundbarbering af aktien først !

[concillado]

Vildt nok, hvor let det er at manipulere kursen på volatile aktier, selvom GEN egentlig ikke burde være så volatil en aktie længere, hvis man ser på trackrecord.

[E_L]

it is only just over a week ago that we were counting down to 2000 ; Mr Market is just giving us a second chance

[E_L]

1.5 to go
!!

[concillado]

Positive thinking EL, I like it!

[concillado]

Let's have a takeover offer just in time for the summer holidays!

[StockBull]

Pæn støtte i 1650 som jeg ser som realistisk retracement niveau inden udgang af Juni. Ufattelig god partnerdel kan muligvis mindske retracement

[E_L]

18/5 15:13
af Parasitism
WUUUHUUU

[E_L]

[Sukkeralf]

soon there again

[concillado]

Compared to the "ATH 1500 scenario" 3 years ago, what would be the biggest counter argument for history not repeating itself in your opinion?

[StockBull]

Ser dog ud til at ufattelig mange er gået ind i Genmab i Maj måned som har det største grønne måneds candlelight i over 10 år så det kunne indikere en måske lidt mindre retracement og exit af den gamle trendkanal fra 2018 ?

[AaBforever]

Stock...og?

[E_L]

-Daratumumab significantly derisked, with 1st line and SC approvals and new disease areas underway – much further developed pipeline and Tepezza and Ofa approved -abundance of cash

[GeorgeBest]

Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility

[GeorgeBest]

Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility - GlobeNewswire

27-May-2020 15:00:10For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200527:nGNX2tTlD1

• Innovative agreement provides flexible model to address Genmab’s
  development and manufacturing needs as programs advance in development
• Rentschler Biopharma’s U.S. site expansion progressing on tra

[GeorgeBest]

LAUPHEIM, Germany and MILFORD, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today that the company has entered into a strategic collaboration with Genmab for the process development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform. This partnership uses an innovative business model which fits well with the expansion plans f